Clifton C. Mo
- Co-authors
- Judith E. KarpChristopher S. HouriganPaul G. RichardsonJacob P. LaubachOmar NadeemAdam S. SperlingOla LandgrenShonali Midha
- Topics
- Multiple Myeloma Research and Treatments (29 papers)Protein Degradation and Inhibitors (15 papers)CAR-T cell therapy research (7 papers)
- Cited by
- HematologyGeneticsOncology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesSpainItaly
In The Last Decade
Clifton C. Mo
42 papers receiving 480 citations
Peers
Comparison fields: 5 of 74
- Hematology 242
- Molecular Biology 216
- Oncology 177
- Pathology and Forensic Medicine 73
- Genetics 69
Countries citing papers authored by Clifton C. Mo
This map shows the geographic impact of Clifton C. Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifton C. Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifton C. Mo more than expected).
Fields of papers citing papers by Clifton C. Mo
This network shows the impact of papers produced by Clifton C. Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifton C. Mo. The network helps show where Clifton C. Mo may publish in the future.
Co-authorship network of co-authors of Clifton C. Mo
This figure shows the co-authorship network connecting the top 25 collaborators of Clifton C. Mo. A scholar is included among the top collaborators of Clifton C. Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifton C. Mo. Clifton C. Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 17 | |
| 12 | 4 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 4 | |
| 16 | 2 | |
| 17 | 24 | |
| 18 | 21 | |
| 19 | 10 | |
| 20 | 5 |
About Clifton C. Mo
Clifton C. Mo is a scholar working on Hematology, Genetics and Oncology, having authored 44 papers that have together received 489 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Protein Degradation and Inhibitors (15 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Hematology (242 citations), Genetics (69 citations) and Oncology (177 citations). Clifton C. Mo has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Judith E. Karp, Christopher S. Hourigan, Paul G. Richardson, Jacob P. Laubach, Omar Nadeem, Adam S. Sperling, Ola Landgren, Shonali Midha, Elizabeth O’Donnell and Dickran Kazandjian. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.